Apexcela

Apexcela is a Thailand-based specialty pharmaceutical company that focuses on the commercialization, marketing, and distribution of innovative biopharmaceuticals and high-quality medicines. Established in 2010 as a joint venture involving the Crown Property Bureau, the company serves as the primary commercial arm for Siam Bioscience, Thailand's first biopharmaceutical manufacturer. Apexcela provides comprehensive services including clinical trial management, regulatory affairs, and market access to facilitate the entry of advanced therapies into the Southeast Asian market. Their product portfolio is centered on biosimilars for oncology, nephrology, and autoimmune diseases, aiming to improve patient access to affordable life-saving treatments. The company plays a strategic role in the Thai healthcare ecosystem by supporting the national goal of pharmaceutical self-reliance.